Stratum Market Research
Contact

Healthcare & Life SciencesUnited StatesUpdated

Oncology devices Market 2026: trade data and key figures

The FDA has 64 510(k) clearances on record for oncology devices devices. In the US, the core industry (Electromedical and electrotherapeutic apparatus manufacturing) had 2,220 establishments in 2025.

1,791enterprises

The EU had 1,791 enterprises in NACE class C2660 (Manufacture of irradiation

€30.54billion

EU enterprises in NACE class C2660 had net turnover of €30.54 billion in 2023

74,126persons employed

NACE class C2660 employed 74,126 people across the EU in 2021

The EU counted 1,791 enterprises in the related industry class.

What this market covers

Equipment used to find and treat cancer, such as radiation systems, ablation tools and infusion devices. Buyers are cancer centers and hospitals.

Typical segments

  • Radiation therapy systems
  • Ablation devices
  • Infusion pumps
  • Surgical oncology tools
ChartFDA 510(k) clearances per year, oncology devices
FDA 510(k) clearances per year, oncology devices01232016: 0 clearances020162017: 2 clearances2018: 2 clearances20182019: 0 clearances2020: 0 clearances20202021: 1 clearances2022: 3 clearances20222023: 1 clearances2024: 1 clearances2025: 1 clearances12025

Source: U.S. Food and Drug Administration

Why this market is moving now

  • US employment in the core industry fell 1% since 2020.

Key figures

Each figure names the source it came from. Open the source list below to read the quoted line.

FigureValueYearSource
The EU had 1,791 enterprises in NACE class C2660 (Manufacture of irradiation, electromedical and electrotherapeutic equipment) in 2023.1,791 enterprises2023Eurostat
EU enterprises in NACE class C2660 had net turnover of €30.54 billion in 2023.30.54 EUR billion2023Eurostat
NACE class C2660 employed 74,126 people across the EU in 2021.74,126 persons employed2021Eurostat
The US had 2,220 private establishments in NAICS 334510 (Electromedical and electrotherapeutic apparatus manufacturing) in 2025.2,220 establishments2025U.S. Bureau of Labor Statistics
NAICS 334510 employed an average of 72,575 people in US private industry in 2025.72,575 jobs2025U.S. Bureau of Labor Statistics
US employment in NAICS 334510 changed by -1% between 2020 (73,147 jobs) and 2025, calculated from BLS figures.-1 % since 20202025U.S. Bureau of Labor Statistics
Average annual pay in US NAICS 334510 was $140,429 in 2025.140,429 USD per year2025U.S. Bureau of Labor Statistics
The FDA has recorded 64 510(k) clearances for devices named "radiation therapy".64 510(k) clearances2026U.S. Food and Drug Administration
7 of those clearances were issued from 2021 to 2025.7 510(k) clearances2025U.S. Food and Drug Administration
Varian Medical Systems, Inc. holds 10 510(k) clearances for devices named "radiation therapy".10 510(k) clearances2026U.S. Food and Drug Administration
Proxima Therapeutics, Inc. holds 5 510(k) clearances for devices named "radiation therapy".5 510(k) clearances2026U.S. Food and Drug Administration
Adac Laboratories holds 3 510(k) clearances for devices named "radiation therapy".3 510(k) clearances2026U.S. Food and Drug Administration
Best Nomos holds 3 510(k) clearances for devices named "radiation therapy".3 510(k) clearances2026U.S. Food and Drug Administration
Victoreen, Inc. holds 3 510(k) clearances for devices named "radiation therapy".3 510(k) clearances2026U.S. Food and Drug Administration
E.I. Dupont De Nemours & Co., Inc. holds 2 510(k) clearances for devices named "radiation therapy".2 510(k) clearances2026U.S. Food and Drug Administration

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
    Quoted lines
    • Figure 1sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs ENT_NR, 2023, 1791
    • Figure 2sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs NETTUR_MEUR, 2023, 30540
    • Figure 3sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs EMP_NR, 2021, 74126
  2. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 334510, 2025 (2026-11-04)
    Quoted lines
    • Figure 4QCEW 2025 annual, US000, private, NAICS 334510, annual_avg_estabs 2220
    • Figure 5QCEW 2025 annual, US000, private, NAICS 334510, annual_avg_emplvl 72575
    • Figure 6QCEW 2020 annual_avg_emplvl 73147; 2025 annual_avg_emplvl 72575
    • Figure 7QCEW 2025 annual, US000, private, NAICS 334510, avg_annual_pay 140429
  3. U.S. Food and Drug Administration: openFDA 510(k) clearances, device_name "radiation therapy" (2026-11-04)
    Quoted lines
    • Figure 8openFDA device/510k device_name:"radiation therapy", sum of counts by decision_date = 64
    • Figure 9openFDA device/510k decision_date 2021-2025 count = 7
  4. U.S. Food and Drug Administration: openFDA 510(k) clearances by applicant, device_name "radiation therapy" (2026-11-04)
    Quoted lines
    • Figure 10applicant.exact "Varian Medical Systems, Inc." count 10
    • Figure 11applicant.exact "Proxima Therapeutics, Inc." count 5
    • Figure 12applicant.exact "Adac Laboratories" count 3
    • Figure 13applicant.exact "Best Nomos" count 3
    • Figure 14applicant.exact "Victoreen, Inc." count 3
    • Figure 15applicant.exact "E.I. Dupont DE Nemours & Co., Inc." count 2

Buyers and suppliers

Who buys

  • Cancer centers
  • Hospitals
  • Ambulatory surgery centers

Companies to watch

Varian Medical Systems, Inc.

10 FDA 510(k) clearances for devices named "radiation therapy".

Proxima Therapeutics, Inc.

5 FDA 510(k) clearances for devices named "radiation therapy".

Adac Laboratories

3 FDA 510(k) clearances for devices named "radiation therapy".

Best Nomos

3 FDA 510(k) clearances for devices named "radiation therapy".

Victoreen, Inc.

3 FDA 510(k) clearances for devices named "radiation therapy".

E.I. Dupont De Nemours & Co., Inc.

2 FDA 510(k) clearances for devices named "radiation therapy".

What the full report covers

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the United States market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days
Compare the editions

Frequently asked questions

How many oncology devices devices are cleared by the FDA?

openFDA lists 64 510(k) clearances for devices named radiation therapy.

Which companies hold the most FDA clearances for oncology devices?

By 510(k) count: Varian Medical Systems, Inc., Proxima Therapeutics, Inc., Adac Laboratories, Best Nomos.

How many US companies are in the oncology devices industry?

BLS counts 2,220 private establishments in NAICS 334510 (Electromedical and electrotherapeutic apparatus manufacturing), the closest official industry.

How many EU companies are in the oncology devices industry?

Eurostat counts 1,791 enterprises in NACE class C2660 (Manufacture of irradiation, electromedical and electrotherapeutic equipment).

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition